Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2014 (2014), Article ID 790192, 4 pages
http://dx.doi.org/10.1155/2014/790192
Case Report

Management of a Patient with Metastatic Colorectal Cancer and Liver Metastases

Tufts University School of Medicine, 800 Washington Street, Suite 7S-7099, Boston, MA 02111, USA

Received 12 December 2013; Accepted 10 February 2014; Published 12 March 2014

Academic Editors: C. Gennatas and K. Tanaka

Copyright © 2014 Muhammad Wasif Saif. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer. Version 3, NCCN, 2013, http://www.nccn.org.
  2. E. Van Cutsem, B. Nordlinger, and A. Cervantes, “Advanced colorectal cancer: ESMO clinical practice guidelines for treatment,” Annals of Oncology, vol. 21, supplement 5, pp. v93–v97, 2010. View at Google Scholar
  3. L. M. Ellis, S. A. Curley, and A. Grothey, “Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab,” Journal of Clinical Oncology, vol. 23, no. 22, pp. 4853–4855, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. W. R. Jarnagin, M. Gonen, Y. Fong et al., “Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade,” Annals of Surgery, vol. 236, no. 4, pp. 397–407, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Adam, “Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases,” Annals of Oncology, vol. 14, supplement 2, pp. ii13–ii16, 2003. View at Google Scholar · View at Scopus
  6. J. Cassidy, S. Clarke, E. Díaz-Rubio et al., “Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer,” Journal of Clinical Oncology, vol. 26, no. 12, pp. 2006–2012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Cassidy, S. Clarke, E. Díaz-Rubio et al., “XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results,” British Journal of Cancer, vol. 105, no. 1, pp. 58–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Zhang, J. Wang, H. Gu et al., “Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: meta-analysis of randomized controlled trials,” Oncology Letters, vol. 3, no. 4, pp. 831–838, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. L. B. Saltz, S. Clarke, E. Díaz-Rubio et al., “Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study,” Journal of Clinical Oncology, vol. 26, no. 12, pp. 2013–2019, 2008. View at Google Scholar
  10. Zaltrap [Package Insert], Sanofi-Aventis U.S., Bridgewater, NJ, USA, 2012.
  11. E. Van Cutsem, J. Tabernero, R. Lakomy et al., “Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen,” Journal of Clinical Oncology, vol. 30, no. 28, pp. 3499–3506, 2012. View at Google Scholar
  12. J. F. Sun, R. R. Wu, C. Norris et al., “Safety of chronic low-dose capecitabine as maintenance therapy in gastrointestinal cancers,” Gastrointestinal Cancer Research, vol. 3, no. 4, pp. 134–140, 2009. View at Google Scholar · View at Scopus
  13. Eloxatin [Package Insert], Sanofi-Aventis U.S., Bridgewater, NJ, USA, 2013.
  14. H. Mentzel, J. Blume, A. Malich, C. Fitzek, J. R. Reichenbach, and W. A. Kaiser, “Cortical blindness after contrast-enhanced CT: complication in a patient with diabetes insipidus,” American Journal of Neuroradiology, vol. 24, no. 6, pp. 1114–1116, 2003. View at Google Scholar · View at Scopus